Adjusting HIV prevalence for survey non-response using mortality rates: an application of the method using surveillance data from Rural South Africa.
BACKGROUND
The main source of HIV prevalence estimates are household and population-based surveys; however, high refusal rates may hinder the interpretation of such estimates. The study objective was to evaluate whether population HIV prevalence estimates can be adjusted for survey non-response using mortality rates.


RESULTS
Data come from the longitudinal Africa Centre Demographic Information System (ACDIS), in rural South Africa. Mortality rates for persons tested and not tested in the 2005 HIV surveillance were available from routine household surveillance. Assuming HIV status among individuals contacted but who refused to test (non-response) is missing at random and mortality among non-testers can be related to mortality of those tested a mathematical model was developed. Non-parametric bootstrapping was used to estimate the 95% confidence intervals around the estimates. Mortality rates were higher among untested (16.9 per thousand person-years) than tested population (11.6 per thousand person-years), suggesting higher HIV prevalence in the former. Adjusted HIV prevalence for females (15-49 years) was 31.6% (95% CI 26.1-37.1) compared to observed 25.2% (95% CI 24.0-26.4). For males (15-49 years) adjusted HIV prevalence was 19.8% (95% CI 14.8-24.8), compared to observed 13.2% (95% CI 12.1-14.3). For both sexes (15-49 years) combined, adjusted prevalence was 27.5% (95% CI 23.6-31.3), and observed prevalence was 19.7% (95% CI 19.6-21.3). Overall, observed prevalence underestimates the adjusted prevalence by around 7 percentage points (37% relative difference).


CONCLUSIONS
We developed a simple approach to adjust HIV prevalence estimates for survey non-response. The approach has three features that make it easy to implement and effective in adjusting for selection bias than other approaches. Further research is needed to assess this approach in populations with widely available HIV treatment (ART).
Nyirenda
Makandwe
M
Africa Centre for Health and Population Studies, University of KwaZulu-Natal, KwaZulu-Natal, South Africa. mnyirenda@africacentre.ac.za
Zaba
Basia
B
Bärnighausen
Till
T
Hosegood
Victoria
V
Newell
Marie-Louise
ML
D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D005260:Female; D015658:HIV Infections / Q000175:diagnosis / Q000453:epidemiology* / Q000401:mortality*; D006306:Health Surveys; D006801:Humans; D008297:Male; D011159:Population Surveillance; D012424:Rural Population / Q000706:statistics & numerical data*; D017678:Sex Distribution; D013019:South Africa / Q000453:epidemiology; D055815:Young Adult
AIDS Res Hum Retroviruses. 2010 Apr;26(4):401-5
20377420
J Hum Hypertens. 2008 Mar;22(3):236-9
18046436
AIDS. 2008 Jan 2;22(1):139-44
18090402
Stat Med. 2000 May 15;19(9):1141-64
10797513
AIDS. 2007 Jul 11;21(11):1467-72
17589193
Int J Epidemiol. 2011 Apr;40(2):318-26
20154009
AIDS. 2002 Mar 8;16(4):643-52
11873009
Sex Transm Infect. 2006 Jun;82 Suppl 3:iii64-70
16735296
J Public Health Med. 1999 Jun;21(2):208-14
10432252
Lancet. 2003 Dec 6;362(9399):1929-31
14667753
Sex Transm Infect. 2008 Aug;84 Suppl 1:i63-i70
18647869
Sex Transm Infect. 2008 Aug;84 Suppl 1:i71-i77
18647870
AIDS. 2009 Mar 13;23(5):621-9
19182677
AIDS. 2003 Oct 17;17(15):2215-25
14523279
AIDS. 2007 Nov;21 Suppl 6:S73-9
18032942
Int J Infect Dis. 2008 Jul;12(4):363-70
18325810
AIDS. 2007 Nov;21 Suppl 7:S29-38
18040162